410 related articles for article (PubMed ID: 15483668)
21. Ex vivo gene transfer to mature skeletal muscle by using adenovirus helper cells.
Kimura S; Ikezawa M; Cao B; Kanda Y; Pruchnic R; Cummins J; Huard J; Miike T; Suzuki S
J Gene Med; 2004 Feb; 6(2):155-65. PubMed ID: 14978769
[TBL] [Abstract][Full Text] [Related]
22. Enhanced expression of recombinant dystrophin following intramuscular injection of Epstein-Barr virus (EBV)-based mini-chromosome vectors in mdx mice.
Tsukamoto H; Wells D; Brown S; Serpente P; Strong P; Drew J; Inui K; Okada S; Dickson G
Gene Ther; 1999 Jul; 6(7):1331-5. PubMed ID: 10455444
[TBL] [Abstract][Full Text] [Related]
23. Long-term transgene expression in the RPE after gene transfer with a high-capacity adenoviral vector.
Kreppel F; Luther TT; Semkova I; Schraermeyer U; Kochanek S
Invest Ophthalmol Vis Sci; 2002 Jun; 43(6):1965-70. PubMed ID: 12037006
[TBL] [Abstract][Full Text] [Related]
24. Restoration of dystrophin expression in mdx mice by intravascular injection of naked DNA containing full-length dystrophin cDNA.
Liang KW; Nishikawa M; Liu F; Sun B; Ye Q; Huang L
Gene Ther; 2004 Jun; 11(11):901-8. PubMed ID: 14985786
[TBL] [Abstract][Full Text] [Related]
25. AAV vector-mediated microdystrophin expression in a relatively small percentage of mdx myofibers improved the mdx phenotype.
Yoshimura M; Sakamoto M; Ikemoto M; Mochizuki Y; Yuasa K; Miyagoe-Suzuki Y; Takeda S
Mol Ther; 2004 Nov; 10(5):821-8. PubMed ID: 15509500
[TBL] [Abstract][Full Text] [Related]
26. Long-term retinal transgene expression with FIV versus adenoviral vectors.
Loewen N; Leske DA; Cameron JD; Chen Y; Whitwam T; Simari RD; Teo WL; Fautsch MP; Poeschla EM; Holmes JM
Mol Vis; 2004 Apr; 10():272-80. PubMed ID: 15094709
[TBL] [Abstract][Full Text] [Related]
27. Restoration of all dystrophin protein interactions by functional domains in trans does not rescue dystrophy.
Gardner KL; Kearney JA; Edwards JD; Rafael-Fortney JA
Gene Ther; 2006 May; 13(9):744-51. PubMed ID: 16307000
[TBL] [Abstract][Full Text] [Related]
28. Expression of human dystrophin following the transplantation of genetically modified mdx myoblasts.
Moisset PA; Gagnon Y; Karpati G; Tremblay JP
Gene Ther; 1998 Oct; 5(10):1340-6. PubMed ID: 9930339
[TBL] [Abstract][Full Text] [Related]
29. Muscle stem cells can act as antigen-presenting cells: implication for gene therapy.
Cao B; Bruder J; Kovesdi I; Huard J
Gene Ther; 2004 Sep; 11(17):1321-30. PubMed ID: 15175641
[TBL] [Abstract][Full Text] [Related]
30. Extended tropism of an adenoviral vector does not circumvent the maturation-dependent transducibility of mouse skeletal muscle.
van Deutekom JC; Cao B; Pruchnic R; Wickham TJ; Kovesdi I; Huard J
J Gene Med; 1999; 1(6):393-9. PubMed ID: 10753064
[TBL] [Abstract][Full Text] [Related]
31. Genetic correction of dystrophin deficiency and skeletal muscle remodeling in adult MDX mouse via transplantation of retroviral producer cells.
Fassati A; Wells DJ; Sgro Serpente PA; Walsh FS; Brown SC; Strong PN; Dickson G
J Clin Invest; 1997 Aug; 100(3):620-8. PubMed ID: 9239410
[TBL] [Abstract][Full Text] [Related]
32. Use of helper-dependent adenoviral vectors of alternative serotypes permits repeat vector administration.
Parks R; Evelegh C; Graham F
Gene Ther; 1999 Sep; 6(9):1565-73. PubMed ID: 10490766
[TBL] [Abstract][Full Text] [Related]
33. [Adeno-associated virus vector carrying human minidystrophin gene SMCKA3999 effectively ameliorates dystrophic pathology in mdx model mice].
Li HH; Zhang SM; Fang SY; Chen CL; Luo YD; Guan Y; Wang DW; Xiao X
Zhonghua Yi Xue Za Zhi; 2003 Sep; 83(17):1513-6. PubMed ID: 14521733
[TBL] [Abstract][Full Text] [Related]
34. Local high-capacity adenovirus-mediated mCTLA4Ig and mCD40Ig expression prolongs recombinant gene expression in skeletal muscle.
Jiang ZL; Reay D; Kreppel F; Gambotto A; Feingold E; Kochanek S; McCarthy SA; Clemens PR
Mol Ther; 2001 Jun; 3(6):892-900. PubMed ID: 11407903
[TBL] [Abstract][Full Text] [Related]
35. Autotransplantation in mdx mice of mdx myoblasts genetically corrected by an HSV-1 amplicon vector.
Bujold M; Caron N; Camiran G; Mukherjee S; Allen PD; Tremblay JP; Wang Y
Cell Transplant; 2002; 11(8):759-67. PubMed ID: 12588108
[TBL] [Abstract][Full Text] [Related]
36. Injection of a recombinant AAV serotype 2 into canine skeletal muscles evokes strong immune responses against transgene products.
Yuasa K; Yoshimura M; Urasawa N; Ohshima S; Howell JM; Nakamura A; Hijikata T; Miyagoe-Suzuki Y; Takeda S
Gene Ther; 2007 Sep; 14(17):1249-60. PubMed ID: 17581597
[TBL] [Abstract][Full Text] [Related]
37. Immune responses against tetracycline-dependent transactivators affect long-term expression of mouse erythropoietin delivered by a helper-dependent adenoviral vector.
Lena AM; Giannetti P; Sporeno E; Ciliberto G; Savino R
J Gene Med; 2005 Aug; 7(8):1086-96. PubMed ID: 15772935
[TBL] [Abstract][Full Text] [Related]
38. Electroporation of corrective nucleic acids (CNA) in vivo to promote gene correction in dystrophic muscle.
Kapsa RM; Wong SH; Quigley AF
Methods Mol Biol; 2008; 423():405-19. PubMed ID: 18370218
[TBL] [Abstract][Full Text] [Related]
39. Reexpression following readministration of an adenoviral vector in adult mice after initial in utero adenoviral administration.
Lipshutz GS; Flebbe-Rehwaldt L; Gaensler KM
Mol Ther; 2000 Oct; 2(4):374-80. PubMed ID: 11020353
[TBL] [Abstract][Full Text] [Related]
40. Forced myofiber regeneration promotes dystrophin gene transfer and improved muscle function despite advanced disease in old dystrophic mice.
Guibinga GH; Ebihara S; Nalbantoglu J; Holland P; Karpati G; Petrof BJ
Mol Ther; 2001 Nov; 4(5):499-507. PubMed ID: 11708887
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
